placeholder image
S. V. Edelman All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Impact of pharmacy benefit manager organizations on diabetes management. 
    Journal of Diabetes Science and Technology. 2026
  • Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: the head-to-head randomized controlled InRange trial. 
    Diabetes, Obesity & Metabolism. 2023
  • InRange: comparison of the second-generation basal insulin analogues glargine 300 U/mL and degludec 100 U/mL in persons with type 1 diabetes using continuous glucose monitoring-study design. 
    Diabetes Therapy. 2020
  • Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: a multicentre, randomized controlled trial using continuous glucose monitoring. 
    Diabetes, Obesity & Metabolism. 2019
    • Review
  • Comparison of second-generation basal insulin analogs: a review of the evidence from continuous glucose monitoring [review]. 
    Diabetes Technology & Therapeutics. 2021
    • Contact
    full name
  • S. V. Edelman
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration